MEOX2 and central nervous system cancer: developed a risk score model based on DNA methylation‐expressed (DME) gene profiles from 259 glioma samples (WHO grades I–III, TCGA database) and identified six DME genes (EMP3, DDIT4L, MEOX2, OCIAD2, TGFB2, TNFRSF12A) associated with survival outcomes [51].